Will mineralocorticoid receptor antagonists give impact on HFpEF pharmacotherapy in addition to SGLT2 inhibitors? [PDF]
Komiyama M, Hasegawa K, Rosano GMC.
europepmc +1 more source
Comparing the Long-Term Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors Versus Mineralocorticoid Receptor Antagonists as Add-On Therapies in the Management of Heart Failure: A Systematic Review. [PDF]
George V +5 more
europepmc +1 more source
Components of Mineralocorticoid Receptor System in Human DRG Neurons Co-Expressing Pain-Signaling Molecules: Implications for Nociception. [PDF]
Mousa SA +8 more
europepmc +1 more source
Kidney Disease and Mineralocorticoid Receptor
openaire +3 more sources
From Receptor to Repair: The Mechanistic Basis of Mineralocorticoid Receptor Antagonism in Acute Kidney Injury and CKD. [PDF]
Liu R, Lu Y, Juncos LA.
europepmc +1 more source
Observation of the therapeutic effect of finerenone, a novel non-steroidal mineralocorticoid receptor antagonist, in patients with non-diabetic CKD. [PDF]
Li F +9 more
europepmc +1 more source
Cardiovascular Outcomes and Hyperkalemia Risk in Patients With Diabetes, Chronic Kidney Disease and Heart Failure: A Real-World Comparison of Non-steroidal versus Steroidal Mineralocorticoid Receptor Antagonists. [PDF]
Okunlola AO +7 more
europepmc +1 more source
Association Between Mineralocorticoid Receptor Antagonist Use With Worsening Renal Function and Prognosis in Patients With Acute Heart Failure. [PDF]
Fujimoto Y +21 more
europepmc +1 more source

